Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS — SIBERIA-2  

Asymptomatic Patients (Stenosis =80%) Clinical Trial

Official title: Independent Randomized Clinical Trial in Carotid Revascularization With MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes With Distal EPS Versus Proximal EPS

Status Recruiting

Clinical Trial Summary

The SIBERIA study demonstrated a clear advantage of CGuard stent implantation over the existing classical stent when using a distal anti-embolic device. At the same time, there is no Level 1 evidence for a difference between the proximal and distal anti-embolic device for the CGuard stent.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Asymptomatic Patients (Stenosis =80%)
• Carotid Stenosis
• Constriction, Pathologic
• Patients With Aterosclerotic Carotid Stenosis
• Symptomatic Patients (Stenosis > 50%)

• NCT number: NCT05257161
• Study type: Interventional
• Source: Meshalkin Research Institute of Pathology of Circulation
• Contact: Andrey A Kaprenko, MD
• Phone: +79139504100
• Email: a_karpenko@meshalkin.ru
• Status: Recruiting
• Phase: N/A
• Start date: November 1, 2021
• Completion date: January 1, 2027